TMFBiologyFool

Brian Orelli

Somewhere between his graduate thesis on BRCA1, a gene that causes hereditary breast cancer, and his postdoctoral fellowship in DNA repair, Brian realized he enjoyed analyzing other people's data more than running his own experiments. Having gotten his first taste of how to analyze stocks from The Motley Fool many years prior, it was only fitting that he came full circle and started writing about biotech, pharmaceutical, and medical device companies for Fool.com. He also covers the health insurance industry to keep from going into binary-event overload. When not writing at The Motley Fool or trade journals like Nature Biotechnology and BioWorld, Brian can be found coaching soccer or hanging out at the beach in his hometown of San Diego.

TMFBiologyFool’s Activity

Mon Jul 27

NL

Article

TMFBiologyFool published an article 1:55 PM

5 Things Biogen's Management Wants You to Know

Tecfidera, more Tecfidera, and how to replace Tecfidera growth.

Fri Jul 24

NL

Article

TMFBiologyFool published an article 5:45 PM

Biogen's Terrible, Horrible, No Good, Very Bad Week

Mixed data and lower-than-expected earnings make for a bad week.

Thu Jul 23

NL

Article

TMFBiologyFool published an article 5:45 PM

Bristol-Myers Squibb Gets a Mixed Message From Investors

The pharma beats expectations, but investors don't seem to care.

Rule Breakers article.

TMFBiologyFool published an update. 2:45 PM

NL

Article

TMFBiologyFool published an article 12:45 PM

Celgene Rolling Along (But You Already Knew That)

After pre-releasing revenue and sales numbers last week, investors got more details on the biotech's second-quarter earnings.

Wed Jul 22

Rule Breakers Boards Post

TMFBiologyFool posted to the Rule Breakers boards. 9:10 PM

Stock Advisor Boards Post

TMFBiologyFool replied to the Stock Advisor boards. 5:04 PM

Hidden Gems article.

TMFBiologyFool published an update. 4:09 PM

NL

Article

TMFBiologyFool published an article 1:31 PM

Natus Medical: This Baby Keeps Growing

Earnings grow faster than revenue as the medical-device maker increases margins.

Tue Jul 21

Rule Breakers Boards Post

TMFBiologyFool replied to the Rule Breakers boards. 7:31 PM

NL

Article

TMFBiologyFool published an article 5:46 PM

Big Week for Biogen

Clinical trial data and earnings! What more could an investor ask for?

NL

Article

TMFBiologyFool published an article 4:27 PM

Celgene Buys Receptos. Is Arena Pharmaceuticals Next?

Both biotechs have S1P1 receptor drugs, but they're not created equal.

Rule Breakers Boards Post

TMFBiologyFool replied to the Rule Breakers boards. 1:51 PM

Mon Jul 20

Rule Breakers Boards Post

TMFBiologyFool replied to the Rule Breakers boards. 5:33 PM

Rule Breakers Boards Post

TMFBiologyFool replied to the Rule Breakers boards. 3:02 PM

Rule Breakers Boards Post

TMFBiologyFool replied to the Rule Breakers boards. 2:59 PM

NL

Article

TMFBiologyFool published an article 2:33 PM

Exelixis' Meteroric Rise From the Ashes

The biotech finally gets a positive clinical trial result in a decently sized market.

Rule Breakers Boards Post

TMFBiologyFool replied to the Rule Breakers boards. 2:12 PM

Thu Jul 16

NL

Boards Post

TMFBiologyFool replied to the Moving Out of the Fast Lane board. 12:16 PM

Re: Changing Gears

If you've got decent writing skills and a propensity for analyzing stocks, consider writing Fool.com. We're freelancers that work remotely. You could probably start now, writing articles after work, and know by the time [more]

NL

Boards Post

TMFBiologyFool replied to the Self-Employed Fools board. 10:58 AM

Re: Where are they

Does Daytona have any co-working places (shared offices where people rent a desk or office)?

-Brian
Senior Biotech Specialist for Fool.com

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 95.38
Player Rank 3474 out of 75192
Score 1324.96
Score Change Today -101.13
Accuracy 66.19%
Active Picks 73
Total Picks 215
Best Pick ALKS (+400.72)
Worst Pick INCY (-1022.14)
Average Score per Pick 6.16
Charms Earned 10
Highest Rated Favorite zzlangerhans
Go to TMFBiologyFool’s CAPS page

Boards Stats & Trivia

Big red star, 1000 posts CAPS All Star
Board Posts 1017
Recs Received 1178
People who have rec'd these posts 459
Recs to Posts Ratio (last 30 days) 7.80
Threads Started 103
Threads Started Percentage 10.13 %
Most Frequent Board Buying or Selling a Home
Very First Post Re: How many is enough? (6/6/2001)
Percentage of Posts Rec'd 49.75 %
Show TMFBiologyFool’s 10 Latest Posts